Search Results - "Broglio, K. R."

Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer by Cabioglu, N, Gong, Y, Islam, R, Broglio, KR, Sneige, N, Sahin, A, Gonzalez-Angulo, AM, Morandi, P, Bucana, C, Hortobagyi, GN, Cristofanilli, M

“…Purpose: Recent studies have indicated that expression of chemokine receptors CXCR4 and CCR7 could be an indicator of the metastatic potential of breast…”
Get full text

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits by Yang, C. H., Gonzalez-Angulo, A. M., Reuben, J. M., Booser, D. J., Pusztai, L., Krishnamurthy, S., Esseltine, D., Stec, J., Broglio, K. R., Islam, R., Hortobagyi, G. N., Cristofanilli, M.

“…Background: Bortezomib (VELCADE®) is a potent inhibitor of the 26S proteasome with broad antitumor activity. We performed a phase II study of bortezomib to…”
Get full text

Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation by Bashoura, L, Gupta, S, Jain, A, Couriel, D R, Komanduri, K V, Eapen, G A, Safdar, A, Broglio, K R, Adachi, R, Dickey, B F

“…Post transplantation constrictive bronchiolitis (PTCB) is the most common pulmonary complication among long-term survivors of allogeneic hematopoietic stem…”
Get full text

Effects of chronic hepatitis C infection on the treatment of breast cancer patients by Morrow, P.K.H., Tarrand, J.J., Taylor, S.H., Kau, S.-W. C., Theriault, R.L., Hortobagyi, G.N., Broglio, K.R., Hahn, K.M.

“…Although hepatitis C (HCV) is the most common blood-borne infection in the United States, little information exists about treatment of breast cancer in the…”
Get full text

PET‐CR AS A SURROGATE FOR SURVIVAL OUTCOMES IN DLBCL: A LITERATURE BASED META‐ANALYSIS by Berry, D.A., Broglio, K.R., Ward, C., Sahin, D., Nielsen, T., Mattiello, F., McGlothlin, A.E., Wendelberger, B.A., Foster, M., Nowakowski, G.S., Kostakoglu, L.

Get full text

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases by Abdalla, Eddie K, Vauthey, Jean-Nicolas, Ellis, Lee M, Ellis, Vickie, Pollock, Raphael, Broglio, Kristine R, Hess, Kenneth, Curley, Steven A

“…To examine recurrence and survival rates for patients treated with hepatic resection only, radiofrequency ablation (RFA) plus resection or RFA only for…”
Get full text

Adult glioma incidence trends in the United States, 1977–2000 by Hess, Kenneth R., Broglio, Kristine R., Bondy, Melissa L.

“…BACKGROUND Several authors have reported an increase in the incidence of brain tumors, especially among the elderly. A more complete understanding of adult…”
Get full text

Weight changes in breast cancer survivors who received adjuvant antiestrogen therapy by Harris, B. M., Broxson, A. C., Anderson, L. A., Engelbrink, J. G., Zalewski, M. A., Broglio, K. R., Hortobagyi, G. N., Green, M. C.

“…Abstract only 6588 Background: Antiestrogen therapy has dramatically improved breast cancer survival rates but weight gain may be problematic. Studies…”
Get full text

Prospective randomized trial evaluating weekly paclitaxel (WP) versus docetaxel in combination with capecitabine (DC) in operable breast cancer by Buzdar, A. U., Green, M. C., Broglio, K. R., Carter, C. D., Valero, V., Ibrahim, N. K., Hunt, K. K., Hortobagyi, G. N.

“…Abstract only 542 Background: Paclitaxel has scheduled-dependant efficacy, and WP is associated with better therapeutic index (J Clin Oncol…”
Get full text

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine by ROMAGUERA, Jorge E, FAYAD, Luis, SARRIS, Andreas H, DANG, Nam H, WANG, Michael, BEASLEY, Virginia, MEDEIROS, L. Jeffrey, KATZ, Ruth L, GAGNEJA, Harish, SAMUELS, Barry I, SMITH, Terry L, CABANILLAS, Fernando F, RODRIGUEZ, Maria A, BROGHO, Kristine R, HAGEMEISTER, Frederick B, PRO, Barbara, MCLAUGHHN, Peter, YOUNES, Anas, SAMANIEGO, Felipe, GOY, Andre

“…To determine the response, failure-free survival (FFS), and overall survival rates and toxicity of rituximab plus an intense chemotherapy regimen in patients…”
Get full text

Genomic of circulating tumor cells in metastatic breast cancer by Reuben, J. M., Lee, B. N., Li, C., Broglio, K. R., Valero, V., Jackson, S., Ueno, N. T., Krishnamurthy, S., Hortobagyi, G. N., Cristofanilli, M.

“…Abstract only 1002 Background: Metastatic breast cancer (MBC) is an incurable condition and palliative treatments are selected by considering pre-treatment…”
Get full text

Trastuzumab treatment and the risk of central nervous system (CNS) metastases by Pinder, M. C., Chang, H., Broglio, K. R., Michaud, L. B., Theriault, R. L., Sahin, A., Buchholz, T., Hortobagyi, G. N., Esteva, F. J.

“…Abstract only 1018 Background: In the era of trastuzumab, HER2-positive breast cancer confers an increased risk of central nervous system (CNS) metastases…”
Get full text

Circulating tumor cells (CTCs) in metastatic breast cancer: Biological value beyond tumor burden by Cristofanilli, M., Guarneri, V., Valero, V., Fritsche, H. A., Broglio, K. R., Reuben, J. M., Lara, J., Krishnamurthy, S., Hortobagyi, G. N.

“…Abstract only 615 Background: The detection of circulating tumor cells (CTCs) can predict progression-free (PFS) and overall survival (OS) in patients with…”
Get full text

Clinical factors that affect breast cancer risk reduction decisions in high risk women tested for the BRCA1/2 genetic mutation by Uyei, A. R., Broglio, K. R., Solomon, T. L., Vogel, K. J., Amos, C. I., Lu, K., Meric-Bernstam, F., Strong, L., Arun, B.

“…Abstract only 1013 Background: Women with an increased risk for breast cancer have many risk reduction options including: prophylactic mastectomy, prophylactic…”
Get full text

Combined-modality treatment for isolated recurrences of breast carcinoma : Update on 30 years of experience at the University of Texas M. D. Anderson Cancer Center and assessment of prognostic factors by HANRAHAN, Emer O, BROGLIO, Kristine R, BUZDAR, Aman U, THERIAULT, Richard L, VALERO, Vicente, CRISTOFANILLI, Massimo, GUOSHENG YIN, KAU, Shu-Wan C, HORTOBAGYI, Gabriel N, RIVERA, Edgardo

“…Abstract BACKGROUND In three prospective, single‐arm studies, the authors previously showed an improved outcome for anthracycline‐naïve patients with isolated…”
Get full text

Incremental Benefit of Histamine Dihydrochloride When Added to Interleukin-2 for Remission Maintenance In Acute Myeloid Leukemia: A Bayesian Meta-Analysis by Berry, Scott M., Broglio, Kristine R., Berry, Donald A.

“…Abstract 2182 A pivotal trial of histamine dihydrochloride (HDC) + interleukin-2 (IL-2) showed a statistically significant benefit for leukemia-free survival…”
Get full text

Central nervous system metastases in patients with high‐risk breast carcinoma after multimodality treatment by Gonzalez‐Angulo, Ana M., Cristofanilli, Massimo, Strom, Eric A., Buzdar, Aman U., Kau, Shu‐Wan, Broglio, Kristine R., Smith, Terry L., Hortobagyi, Gabriel N.

“…BACKGROUND The current study was performed to determine the incidence of central nervous system (CNS) metastases and to examine associated disease…”
Get full text

Lack of association between amplification of her‐2 and response to preoperative taxanes in patients with breast carcinoma by Gonzalez‐Angulo, Ana M., Krishnamurthy, Savitri, Yamamura, Yuko, Broglio, Kristine R., Pusztai, Lajos, Buzdar, Aman U., Hortobagyi, Gabriel N., Esteva, Francisco J.

“…BACKGROUND The objective of the current study was to determine whether her‐2 amplification was associated with a pathologic response to preoperative…”
Get full text